06/12/2025
5:28 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
3:18 PM | Editas Medicine (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:18 PM | Connaughton Bernadette (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:18 PM | Editas Medicine (Issuer)
Levy Elliott M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:19 PM | Editas Medicine (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:19 PM | Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
5:36 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
5:37 PM | Burkly Linda (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
5:39 PM | Editas Medicine (Issuer)
Parison Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
4:28 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
4:32 PM | Editas Medicine (Subject)
O'Neill Gilmore Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for EDIT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. |
05/14/2025
6:06 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:04 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
3:32 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2025
3:37 PM | Editas Medicine (Filer)
| Form ARS | |
04/04/2025
3:38 PM | Editas Medicine (Filer)
| Form PRE 14A | |
03/27/2025
3:41 PM | Editas Medicine (Issuer)
Lucera Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2025
3:33 PM | Burkly Linda (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2025
3:37 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2025
11:15 PM | Editas Medicine (Filer)
| Form EFFECT | |
03/20/2025
3:30 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
4:10 PM | Editas Medicine (Filer)
| Form POS AM | |
03/05/2025
3:43 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:44 PM | Editas Medicine (Issuer)
Lucera Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:06 PM | Editas Medicine (Filer)
| Form POSASR | |
02/28/2025
3:35 PM | Burkly Linda (Reporting)
Editas Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
7:45 AM | Deep Track Capital, LP (Filed by)
Editas Medicine (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
8:03 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
3:17 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:37 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:40 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
1:30 PM | Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:57 AM | Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:36 AM | Editas Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:33 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
6:04 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
12:10 PM | Editas Medicine (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/06/2024
3:18 PM | Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:20 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:06 AM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
4:02 PM | Burkly Linda (Reporting)
Editas Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s worst nightmare (Ad) The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washington… even Trump’s obsession with seizing Greenland.
There’s a singular force that connects the dots…
And it could threaten to transform American life – and your wealth – forever.  You can get all the details here. |
07/22/2024
4:01 PM | Editas Medicine (Issuer)
Mei Baisong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
6:23 PM | Editas Medicine (Subject)
Mei Baisong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
3:17 PM | Burkly Linda (Reporting)
Editas Medicine (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
5:28 AM | Editas Medicine (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/27/2024
4:02 PM | Editas Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
